X0206 3 2017-07-12 0 0001653821 CEN BIOTECH INC CENBF 0001736911 Byrne Joseph A. 300-3295 QUALITY WAY WINDSOR, ONTARIO, CANADA A6 N8T 3R9 ONTARIO, CANADA 1 1 Chief Executive Officer Common Stock 12894 D Convertible Note 1.6000 2016-08-17 2020-08-17 Common Stock 76123 D Joseph Byrne (the "Reporting Person") was appointed to his positions with CEN Biotech, Inc. (the "Issuer") on July 12, 2017 and owned 12,894 shares of the Issuer's common stock at such date. The Reporting Person resigned from all positions with the Issuer on November 13, 2019. The Reporting Person was appointed as President and a member of the Board of the Issuer effective April 19, 2021. The Reporting Person also beneficially owned, on July 12, 2017, a convertible note with 76,123 shares issuable upon conversion of same. /s/ Joseph Byrne 2021-04-22